4D Molecular Therapeutics, Inc.
FDMT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in 4D Molecular Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −2 vs. Q4 2022
- Shares held
- 30.4M
- +2.40M (+8.6%) vs. Q4 2022
- Total value
- $522.3M
- −$99.5M (−16.0%) vs. Q4 2022
- New holders
- 13
- 40 more added
- Sold out
- 15
- 24 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FDMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $771.2M |
| Q1 2026 | 153 | $471.4M |
| Q4 2025 | 153 | $400.5M |
| Q3 2025 | 134 | $343.2M |
| Q2 2025 | 121 | $149.9M |
| Q1 2025 | 126 | $139.8M |
| Q4 2024 | 146 | $260.6M |
| Q3 2024 | 140 | $629.2M |
| Q2 2024 | 143 | $1.20B |
| Q1 2024 | 147 | $1.79B |
| Q4 2023 | 111 | $859.8M |
| Q3 2023 | 110 | $533.6M |
| Q2 2023 | 100 | $745.3M |
| Q1 2023 | 94 | $522.3M |
| Q4 2022 | 96 | $621.9M |
| Q3 2022 | 88 | $210.4M |
| Q2 2022 | 90 | $181.7M |
| Q1 2022 | 80 | $395.3M |
| Q4 2021 | 77 | $541.8M |
| Q3 2021 | 63 | $515.1M |
| Q2 2021 | 56 | $400.0M |
| Q1 2021 | 64 | $664.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding 4D Molecular Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Diametric Capital, LP | 0 | $0 | 0.00% | −15,554−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −12,758−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −12,631−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −6,241−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −1,671−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| McElhenny Sheffield Capital Management, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |